Flt3 ligand therapy for recipients of allogeneic bone marrow transplants expands host CD8 alpha(+) dendritic cells and reduces experimental acute graft-versus-host disease.

Source:http://linkedlifedata.com/resource/pubmed/id/11861301

Blood 2002 Mar 1 99 5 1825-32

Download in:

View as

General Info

PMID
11861301